ConvaTec Group (OTCMKTS:CNVVY) Raised to “Strong-Buy” at Sanford C. Bernstein

ConvaTec Group (OTCMKTS:CNVVY) was upgraded by stock analysts at Sanford C. Bernstein to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports.

Separately, Peel Hunt raised ConvaTec Group from a “moderate buy” rating to a “strong-buy” rating in a research report on Tuesday, October 28th. Two analysts have rated the stock with a Strong Buy rating, According to MarketBeat, the stock has an average rating of “Strong Buy”.

ConvaTec Group Stock Performance

Shares of CNVVY opened at $12.64 on Wednesday. The company’s fifty day moving average is $12.70 and its two-hundred day moving average is $12.77. ConvaTec Group has a fifty-two week low of $11.57 and a fifty-two week high of $16.65.

ConvaTec Group Company Profile

ConvaTec Group is a global medical products and technologies company focused on developing therapies and technologies for the management of chronic health conditions. The company’s portfolio spans four core business areas—Advanced Wound Care, Ostomy Care, Continence & Critical Care, and Infusion Devices—which are designed to improve patient outcomes and enhance quality of life for people living with long-term health challenges. ConvaTec’s product range includes proprietary wound dressings, ostomy and continence management systems, and safety-engineered infusion sets.

Headquartered in Reading, United Kingdom, ConvaTec serves customers in over 100 countries through a network of manufacturing, distribution, and customer support operations.